FIRM FIXED PRICESMALL BUSINESS SET ASIDE - TOTAL
PEDIASTENT LLC - IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.
PIID: HHSN268201600038CSolicitation ID: PHS20161
Signed Date: Feb 9, 2026Effective Date: Sep 26, 2016End Date: Closed on Mar 22, 2022
Key Details
Description
IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.
Contractor Information
Similar Awards
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NATIONAL TOXICOLOGY PROGRAM
RESEARCH TRIANGLE INSTITUTE
$54.3M
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NATIONAL TOXICOLOGY PROGRAM
RESEARCH TRIANGLE INSTITUTE
$54.3M
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NTP
MRIGLOBAL
$50.9M
IGF::CL::IGF WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER
FRED HUTCHINSON CANCER RESEARCH CENTER
$49.7M
IGF::OT::IGFCHEMISTRY SERVICES FOR THE NTP
BATTELLE MEMORIAL INSTITUTE
$43.2M
Stay Updated
Get notified about new opportunities matching your interests.